STOCKWATCH
·
Pharmaceuticals
New Launch2 Jul 2025, 11:42 am

Lincoln Pharmaceuticals' New Manufacturing Facility Successfully Completes Trial Run

AI Summary

Lincoln Pharmaceuticals Ltd. has announced that its new manufacturing facility located at Block No-176, Trimul Estate, Khatraj, Dis-Gandhinagar, Gujarat has successfully completed its trial run. The facility is expected to commence the commercial production of APIs (Active Pharmaceutical Ingredients) within 1 to 2 years, depending on additional product permission from the Food & Drugs Control Administration. The proposed capacity addition is 1.2 Tonne Per Annum, with an investment of approximately INR 4 Cr. The mode of financing is internal accruals. The rationale behind this expansion is to cater to additional market demand and internal consumption.

Key Highlights

  • New manufacturing facility successfully completes trial run
  • Expected to commence commercial production within 1-2 years
  • Proposed capacity addition of 1.2 Tonne Per Annum
  • Investment of approximately INR 4 Cr
  • Expansion aimed at catering to additional market demand and internal consumption
LINCOPH
Pharmaceuticals
LINCOLN PHARMACEUTICALS LTD.

Price Impact